Line 10: |
Line 10: |
| * '''HIGH''' IPF%, Prolonged PT / aPTT | | * '''HIGH''' IPF%, Prolonged PT / aPTT |
| * What happens to platelets after they help form a clot? | | * What happens to platelets after they help form a clot? |
− |
| |
| * [[DIC]] | | * [[DIC]] |
− | ** Most Common Etiologies
| |
− | *** '''Bacterial sepsis''' (83%), '''Trauma''' (31%), '''Cancer''' (e.g. APML, 6.8%), placental abruption, preeclampsia, amniotic fluid embolism, burn, hyperthermia, rhabdomyolysis, infection, transfusion reaction (ABO incompatibility), snake venom, aortic aneurysm
| |
− | ** Pathogenesis
| |
− | *** Expression of the transmembrane glycoprotein TF (which activates factor VII and the extrinsic pathway)
| |
− | *** Consumption of clotting factors
| |
− | *** Widespread micro and macrovascular thrombosis, depletion of fibrinogen and fibrin clot formation
| |
− | *** Platelets are trapped in the clots
| |
− | *** Plasminogen --> Plasmin also upregulated, leading to large increase in clot breakdown and release of [[FDPs]].
| |
− | ** Diagnostic Algorithm: Score of 5+ points strongly associated with DIC
| |
− | *** Presence of a disease known to be associated with DIC (2 pts)
| |
− | *** Platelets < 100k (1 pt), < 50k (2 pt)
| |
− | *** Fibrin degradation products (FDPs) (e.g. d-dimer): moderate increase (2 pt), strong increase (3 pt)
| |
− | *** PT > 3s (1 pt), > 6s (2 pt)
| |
− | *** Fibrinogen < 1 g/L (1 pt)
| |
− | ** Treatments and Evidence Behind Them:
| |
− | *** Basically don't get it.
| |
− | *** Treat underlying condition
| |
− | *** Treatment is lousy. Evidence behind treatment is likewise lousy.
| |
− | *** Platelets, cryo, FFP
| |
− | ** Morbidity/Mortality is 20-50%
| |
− |
| |
| * ITP | | * ITP |
| * TTP | | * TTP |